First, C6 cells, a rat glioma cell line (Benda et al., 1968), produced a Δlog(Emax/EC50) β-AR agonist fingerprint that did not correspond to either exclusively human β1-AR or human β2-AR expression profiles (Figure 3A). The gene discussed is ADRB1; the disease is central nervous system cancer.